Clinical Trial Update: The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial [Phase 3]

View source ↗

Summary

The HOME Trial (Phase 3), a randomized controlled study evaluating the metabolic effects of hyperinsulinaemia in Type 2 Diabetes Mellitus, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Bethesda General Hospital, Hoogeveen | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED